Urine VMA screening for neuroblastoma: is it worth the cost?
Hallett, G.W.
Pediatrics 51(4): 757
1973
ISSN/ISBN: 0031-4005 PMID: 4697529 Document Number: 59531
Document emailed within 1 workday
Related Documents
Sawada, T.; Shikata, T.; Matsumura, T.; Kawakatsu, H.; Sugimoto, T. 1994: Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group Progress in Clinical and Biological Research 385: 371-375Brock, D.J. 1996: Cost effectiveness of antenatal screening for cystic fibrosis. Realistic cost must be established for genetic counselling in two step screening Bmj 312(7035): 908; Author Reply 910
Kinoshita, Y.; Yamada, S.; Haraguchi, K.; Takayanagi, T.; Mori, Y.; Takahashi, T.; Haruki, E. 1988: Determination of vanillylmandelic acid, vanillactic acid, and homovanillic acid in dried urine on filter-paper discs by high-performance liquid chromatography with coulometric electrochemical detection for neuroblastoma screening Clinical Chemistry 34(11): 2228-2230
Hiyama, E. 2008: Neuroblastoma screening in Japan: population-based cohort study and future aspects of screening Annals of the Academy of Medicine Singapore 37(12 Suppl): 88
Legro, R.S.; Shackleford, D.P.; Moessner, J.M.; Gnatuk, C.L.; Dodson, W.C. 1997: ART in women 40 and over. Is the cost worth it? Journal of Reproductive Medicine 42(2): 76-82
Jerger, J. 2001: Are the benefits worth the cost? Journal of the American Academy of Audiology 12(8): 4p Preceding 383
Salling, A.L. 1977: Reorganized patient groups has cost something but is was worth it Sygeplejersken 70(49): 13
Bari, N.; Kendall, P. 1995: Intensive care in the developing world: is it worth the cost? Jpma. Journal of the Pakistan Medical Association 45(7): 169-170
Moulding, T. 1971: Chemoprophylaxis of tuberculosis: when is the benefit worth the risk and cost? Annals of Internal Medicine 74(5): 761-770
Konieczny, A.; Ryba, M.; Czyzewska-Buczyńska, A.; Hruby, Z. 2013: Significance of podocytes isolated from urine as a marker of glomerulonephritis activity--is the game worth of a candle? Przeglad Lekarski 70(3): 165-168
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510
Bassett, I.V.; Govindasamy, D.; Erlwanger, A.S.; Hyle, E.P.; Kranzer, K.; van Schaik, N.; Noubary, F.; Paltiel, A.D.; Wood, R.; Walensky, R.P.; Losina, E.; Bekker, L.-G.; Freedberg, K.A. 2014: Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Plos one 9(1): E85197
Levy, H.L.; Madigan, P.M.; Shih, V.E. 1972: Massachusetts metabolic disorders screening program. I. Technics and results of urine screening Pediatrics 49(6): 825-836
Vejlşgaard, R.; Justesen, T. 1972: Bacteriological screening of urine. a comparative study of some new screening methods for detection of significant bacteriuria Ugeskrift for Laeger 134(38): 1991-1995
Thomas, C.M.; Schmid, R.; Cameron, S. 2010: Is it worth paying more for emergency hormonal contraception? the cost-effectiveness of ulipristal acetate versus levonorgestrel 1.5 mg Journal of Family Planning and Reproductive Health Care 36(4): 197-201
Zaslau, S. 2012: Placement of prophylactic midurethral sling at time of hysterectomy...are the potential associated problems worth the additional cost and risk? Canadian Journal of Urology 19(5): 6431
Criado, F.J. 1994: Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost? Journal des Maladies Vasculaires 19 Suppl A: 178-182
Campion, P.; Lalonde-Dupuis, D. 1991: Neuroblastoma screening Canadian Nurse 87(9): 17-19
Melchert, H.U.; Hoffmeister, H. 1978: More on gas-liquid chromatographic determination of homovanillic and vanillylmandelic acids in urine from cases of neuroblastoma Clinical Chemistry 24(5): 842-843
Trehu, E.G.; Cooper, J.N. 1992: Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature Southern Medical Journal 85(3): 248-254